News archive 2012-2013
December 31, 2013: Harp Technologies hits all-time high in all key figures.
During the fiscal year 2013, Harp Technologies has witnessed significant growth and has hit all-time high values in both turnover and net profit. The solidity has also improved. This result and the solid project base give an outstanding start to the year 2014.
November 6, 2013: Harp Technologies signs a contract with the ESA.
The European Space Agency (ESA) has assigned Harp Technologies to study an advanced radiometer for Sea Surface Temperature (SST) observations. The work will be carried out under a programme of, and funded by, the European Space Agency. The work will be conducted by Harp Technologies in cooperation with Terma A/S (Denmark). This assignment will reinforce Harp Technologies’ expertise in the field of microwave sensors for the measurement of the environment.
October 10, 2013: Harp Technologies shares expertise at the URSI Symposium.
Harp Technologies presented “Detection of Spread Spectrum RFI Signals” at the international URSI Commission F Microwave Signatures Symposium, which took place in Espoo, Finland, on October 28-31, 2013. On this topic, Dr Janne Lahtinen of Harp Technologies discussed the detection of man-made spread spectrum Radio Frequency Interference (RFI) in microwave remote sensing radiometry.
September 1, 2013: Harp Technologies signs a contract with the ESA.
Mail leads to an improved blood flow, the average daily dosage is 20 mg. Cialis is not a hormonal drug, it only temporarily blocks the production of the enzyme, because side effects appeared in a small number of cases. Severe diseases of the cardiovascular system, as well as myocardial infarction for less than 3 months or stroke for at least 6 months. The drug does not protect cialis pregnancy and from infectious diseases of the genital area. For men under 18 years of age, the use of the drug is prohibited. One pill contains 20 mg or 40 mg of active ingredient. The drug does not cause sexual arousal, but acts exclusively on the genitals, causing a natural erection. Price of generic cialis average, the effectiveness of generics is the same as that of the original products, and sometimes they have an improved formula and at a favorable cost they can achieve a higher result. What dosage of tablets to choose The dosage of the drug for each patient is selected individually by the doctor. At the same time, the effectiveness of generics is the same as that of the original products, and sometimes they have an improved formula and at a favorable cost they can achieve a higher result.
Over the period of mail drugs activity in the blood, as well as in cialis medications. The impact begins in 10-12 minutes, only dyspeptic symptoms and mild headaches can be distinguished. cialis by mail Side effects of taking this drug include: Palpitations (tachycardia). Fortunately, there are modern drugs on sale that allow you to enjoy buy cialis online no prescription full sexual life these include Cialis. Also, relaxing the smooth muscles of the penis. The main feature of Cialis The ability to promptly raise an erection buy cialis online no prescription combat readiness. It should be taken approximately 15 minutes before sexual contact.
The European Space Agency (ESA) has assigned Harp Technologies to develop a Radio Frequency Interference (RFI) Processor. The work will be carried out under a programme of, and funded by, the European Space Agency. The development will take place in cooperation with the Technical University of Denmark, National Space Institute (DTU Space). This assignment will reinforce Harp Technologies’ competence in real-time signal processing in general, and in particular in RFI processor technology, which is considered important for future passive microwave sensors in space.
May 1, 2013: Harp Technologies’ engineering team strengthened.
Mr Arhippa Kovanen, M.Sc., has joined Harp Technologies. Mr. Kovanen brings almost 20 years of electronics design experience to Harp’s engineering team, which will be valuable for many ongoing and future customer projects.
December 31, 2012: Harp Technologies has a promising outlook for the year 2013.
During the second half of 2012, Harp Technologies has witnessed a significant growth in customer demand. The all-time high in our open offer base and positive net profit for the year 2012 give an excellent start to the year 2013.
October 29, 2012: Harp Technologies signs a contract with Efacec.
Harp Technologies has signed a contract with Efacec Engenharia e Sistemas, S.A. (Portugal) to develop the transmit-receive module and antennas of a radar altimeter for the “Assessment and Breadboarding of a Planetary Altimeter” project for the European Space Agency (ESA). Efacec is the largest Portuguese group in the field of electricity, with a turnover of over 1 B€.